Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1982-2-25
|
pubmed:abstractText |
Preinjection of a low dose of cyclophosphamide (Cy) (500 microgram/mouse) either delayed or inhibited tumor appearance following the inoculation of transplantable 3-methylcholanthrene-induced fibrosarcomas in inbred male C3H/HeJ mice. This dose of Cy decreased the spleen weight by 13% and the total spleen cell count by 23%. However, the same dose could potentiate the footpad swelling reaction (FPSR) measured against Staphylococcus aureus antigen. Splenic lymphocytes from Cy-treated animals showed increased blastogenic response against phytohemagglutinin-M and bacterial lipopolysaccharide. Thus 500 micrograms Cy/animal may have depleted suppressor cell populations leading to: a) an increase in FPSR, b) increased blastogenic transformation of lymphocytes, and c) tumor growth inhibition.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0027-8874
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
67
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1341-5
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:6947115-Animals,
pubmed-meshheading:6947115-Cell Line,
pubmed-meshheading:6947115-Cyclophosphamide,
pubmed-meshheading:6947115-Dose-Response Relationship, Drug,
pubmed-meshheading:6947115-Fibrosarcoma,
pubmed-meshheading:6947115-Immunity, Cellular,
pubmed-meshheading:6947115-Lymphocyte Activation,
pubmed-meshheading:6947115-Male,
pubmed-meshheading:6947115-Mice,
pubmed-meshheading:6947115-Mice, Inbred C3H,
pubmed-meshheading:6947115-Neoplasm Transplantation,
pubmed-meshheading:6947115-Spleen
|
pubmed:year |
1981
|
pubmed:articleTitle |
Low-dose cyclophosphamide inhibition of transplantable fibrosarcoma growth by augmentation of the host immune response.
|
pubmed:publicationType |
Journal Article
|